Scientists led by Dr. Craig Mello of The University of Massachusetts have developed a genetic tool – CRISPR [clustered regularly interspaced short palindromic repeats] – to revolutionize the way stem cells are applied to treat genetic diseases, such as sickle cell or thalassemia. CRISPR aims to expedite and improve upon the process of translational genomics, in which the patient’s stem cells are extracted, altered to repair the damaged gene, and then transplanted back to the patient.
In theory, translational genomics allows stem cells to repair the faulty genes that cause intractable diseases. In practice, however, the current approaches have proved costly and time consuming. Researchers are optimistic that with further testing, CRISPR may provide a fast and practical tool for repairing virtually any gene, resulting in stem cell therapies for patients suffering from a wide range of genetic diseases and conditions.
The research is an example of the potential for stem cell regenerative medical therapies to effectively treat seemingly intractable and incurable conditions. To learn more about stem cells and how to insure immediate access to emerging personalized regenerative treatments by banking your own valuable stem cells, please visit StemSave or call 877-783-6728 (877- StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.